TLR9 agonists alleviate diabetic condition by promoting the maturation of differentiated bone marrow mesenchymal stem cells in rats. - Liu C; Zheng H; Lu P; Tian J; Hu Y; Yao L; Sun T (Pakistan journal of pharmaceutical sciences, 2026)